Welcome to MS Views and News blog


MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 28, 2018

CMSC INforMS: Researchers Identify New Subtype of Multiple …

  • MS Research Study and Reports
    /
Sept 5, 2018 Researchers have discovered a new subtype of multiple sclerosis (MS), providing a better understanding of the disease…
MS Research Study and Reports

September 28, 2018

ESTATE PLANNING – for those you love

  • Misc. MS Related
    /
  • Misc. Tips - Non MS Related
    /
Creating your estate plan is easier than you think We never know what could happen tomorrow. But we do know…
Misc. MS Related

September 23, 2018

Therapeutic potentials of ginger for treatment of Multiple sclerosis: A review with emphasis on its immunomodulatory, anti-inflammatory and anti-oxidative properties.

  • MS Research Study and Reports
    /
  • Vitamins and Supplements
    /
Review article Jafarzadeh A, et al. J Neuroimmunol. 2018. Show full citation Abstract Multiple sclerosis (MS) is characterized by chronic…
MS Research Study and Reports

September 23, 2018

The Bayesian risk estimate at onset (BREMSO) correlates with cognitive and physical disability in patients with early multiple sclerosis.

  • MS Research Study and Reports
    /
Abstract BACKGROUND: Prevention of long-term disability is the goal of therapeutic intervention in Relapsing Remitting MS (RRMS). The Bayesian Risk Estimate…
MS Research Study and Reports

September 23, 2018

Things to Know About Flu Shots if You Have MS

  • Misc. MS Related
    /
 SEPTEMBER 11, 2018   BY ED TOBIAS The start of flu season here in the United States is just a few weeks…
Misc. MS Related

September 23, 2018

Gilenya More Effective Than Avonex in Lowering Relapse Rates, New Lesions in Children with Relapsing MS, Phase 3 Trial Shows

  • Pediatric MS
    /
SEPTEMBER 17, 2018 BY PATRICIA INACIO, PHD   IN ALEXA, NEWS. Two years of treatment with oral Gilenya (fingolimod) significantly reduced the rate of relapses…
Pediatric MS

September 23, 2018

Learning to Advocate for Yourself with MS: A Guide

  • For the Benefit of the Patient
    /
  • Misc. MS Related
    /
When you speak up or act on behalf of your rights and well-being, you’re self-advocating. If you have multiple sclerosis…
For the Benefit of the Patient

September 23, 2018

More Than Just Spasms and Pain: What It’s Like to Live with MS

  • An MS Patients Story
    /
Written by Caroline Craven on September 22, 2018 Feeling disconnected from their bodies, people with multiple sclerosis find ways to…
An MS Patients Story

September 22, 2018

What Do We Know About Pediatric MS?

  • Multiple Sclerosis
    /
  • Pediatric MS
    /
Prevalence Although MS occurs most commonly in adults, it is also diagnosed in children and adolescents. Estimates suggest that 8,000-10,000 children…
Multiple Sclerosis

September 21, 2018

Trial of fingolimod vs interferon beta-1a in pediatric multiple sclerosis

  • MS Drug Therapies
    /
  • Pediatric MS
    /
New England Journal of Medicine — Chitnis T, et al. | September 14, 2018 In this phase 3 trial, researchers compared fingolimod with interferon…
MS Drug Therapies

Categories

Latest Blog Posts